World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01403142
Date of registration: 25/07/2011
Primary sponsor: Columbia University
Public title: Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant
Scientific title: Optical Coherence Tomography to Evaluate Cardiac Allograft Vasculopathy in Patients Undergoing Clinically Indicated Angiographies Post Heart Transplant
Date of first enrolment: July 2011
Target sample size: 50
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01403142
Study type:  Observational
Study design:  Observational Model: Case-Only, Time Perspective: Prospective  
Countries of recruitment
United States
Contacts
Name:   Lauren Privitera, MPH
Address: 
Telephone: 212-305-7061
Email: lp2183@columbia.edu
Affiliation: 
Name:   Lauren Privitera
Address: 
Telephone: 212-342-3488
Email: lp2183@columbia.edu
Affiliation: 
Name:   Gioria Weisz, MD
Address: 
Telephone:
Email:
Affiliation:  Columbia University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Post heart transplant patients

- Patients presenting for their routine annual or clinically indicated coronary
angiogram post-heart transplant. The decision for coronary angiogram will be made by
the treating physician from the heart-failure-transplant team (not by the physician
who will do the angiogram)

- Clinically suspect or evidence of CAV in previous coronary angiogram

- Age > 18

- Written informed-consent obtained

Exclusion Criteria:

- Any complications that occur during routine biopsy of the coronary arteries during
the same cath-lab visit

- Baseline renal failure with Cr > 1.8

- Contraindication for anticoagulation

- Any other condition that in the opinion of the investigators would alter the safety
of participation, or interfere with the ability to adhere to study procedures.



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Cardiac Allograft Vasculopathy
Heart Transplant Recipients
Intervention(s)
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
AAAI1023
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history